For this budget, I hope the central government would address a fundamental challenge in our healthcare system, which has to be addressed at a policy level.
India depends upon import for more than 75 percent of medical device requirements and patented drugs, thus making healthcare unaffordable to the masses and losing precious foreign exchange. While we are big on generic drugs, new molecule development and patenting in the country is lacklustre.
Data from World Intellectual Property Organisation (WIPO) shows that South Korea has 4,451 patent filing per 1 million population, Japan has 3,716 ad China has 541. Compared to these,